Alfred Sandrock
CEO, President at Voyager Therapeutics, Inc. (VYGR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $184K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 3SEC | VYGRVoyager Therapeutics, Inc. | Sell Plan | 11,511472,549 held (−2%) | $3.87 | $45K | -50.9% |
| Feb 26SEC | VYGRVoyager Therapeutics, Inc. | Sell Plan | 14,197484,060 held (−3%) | $3.79 | $54K | -49.9% |
| Feb 20SEC | VYGRVoyager Therapeutics, Inc. | Sell Plan | 11,732498,257 held (−2%) | $3.41 | $40K | -44.3% |
| Feb 11SEC | VYGRVoyager Therapeutics, Inc. | Sell | 12,192509,989 held (−2%) | $3.78 | $46K | -49.7% |
- Sell
CEO, President Alfred Sandrock sold $45K of VYGR at $3.87 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Alfred Sandrock sold $54K of VYGR at $3.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Alfred Sandrock sold $40K of VYGR at $3.41 — pre-scheduled 10b5-1 plan sale.